NCT01636193View on ClinicalTrials.gov

Drug Use Investigation for ROTARIX®

CompletedOBSERVATIONAL

Enrollment

1,607

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Oral Rotarix®

2 doses administered orally.

OTHER

Data collection

Safety data will be collected through the check of health observation diary and interview of vaccinee's parent.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY